Key result
Transcatheter aortic valve replacement (TAVR) in a patient with a continuous-flow left ventricular assist device was complicated by TAVR thrombosis.
Why the study?
Aortic insufficiency is a frequent problem after continuous-flow LVAD implantation, and TAVR is a potential treatment option, but data on complications like thrombosis in this population are limited.
Case Report (n=1)
This first reported case of TAVR thrombosis in an LVAD patient highlights a potential major complication as TAVR becomes more common in this population.
Warrants vigilance for thrombosis after TAVR in LVAD patients; single case leaves open optimal antithrombotic strategies.
Aortic insufficiency (AI) is a frequent problem after continuous-flow left ventricular assist device (LVAD) implantation and results in increased morbidity and mortality. Advances in transcatheter aortic valve replacement (TAVR) technology have resulted in this being discussed as a potential option for LVAD patients with AI. While small case series have been published, we report the first case of TAVR thrombosis in an LVAD patient. This case highlights a major diagnostic and management dilemma that should become more present if this strategy becomes more widespread.
No takes yet. Share an insight, caveat, or question.
Rao et al. (2020) conducted a case report in Aortic insufficiency in patient with continuous-flow left ventricular assist device (n=1). Transcatheter aortic valve replacement (TAVR) was evaluated on TAVR thrombosis. Transcatheter aortic valve replacement (TAVR) in a patient with a continuous-flow left ventricular assist device was complicated by TAVR thrombosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: